KaneJM, CarsonWH, SahaAR, McQuadeRD, IngenitoGG, ZimbroffDL, et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry2002; 63: 763–71.
DuggalHS. Aripiprazole-induced improvement in tardive dyskinesia. Can J Psychiatry2003; 48: 771–2.
4.
NaranjoCA, BustoU, SellersEM, SandorP, RuizI, RobertsEA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
